OPTUS Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
OPTUS Pharmaceutical has a total shareholder equity of ₩134.5B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩149.5B and ₩15.0B respectively. OPTUS Pharmaceutical's EBIT is ₩8.2B making its interest coverage ratio -3.8. It has cash and short-term investments of ₩68.5B.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | -3.8x |
| Cash | ₩68.52b |
| Equity | ₩134.45b |
| Total liabilities | ₩15.01b |
| Total assets | ₩149.46b |
Recent financial health updates
No updates
Recent updates
There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise
Mar 25
OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality
Mar 13The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence
Apr 05DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit
Mar 09DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 10
How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 12Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?
Dec 08Financial Position Analysis
Short Term Liabilities: A131030's short term assets (₩91.8B) exceed its short term liabilities (₩13.1B).
Long Term Liabilities: A131030's short term assets (₩91.8B) exceed its long term liabilities (₩1.9B).
Debt to Equity History and Analysis
Debt Level: A131030 is debt free.
Reducing Debt: A131030 had no debt 5 years ago.
Debt Coverage: A131030 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A131030 has no debt, therefore coverage of interest payments is not a concern.